Volume 11 | Issue 2
ISSN (Print): 1759-1376
ISSN (Online): 2041-9457
Several definitions exist in clinical guidelines and randomised controlled trials. van Diepen et al (2017) describe cardiogenic shock as a primary cardiac disorder causing a reduction in cardiac output, resulting in clinical and biochemical signs of end-organ hypoperfusion, despite adequate circulating volume. Thiele et al (2015) outline a clinical spectrum that ranges from signs of mild hypoperfusion to profound shock with evidence of multi-organ dysfunction.
